It's a bit last minute, but we have an RA/junior postdoc position available in my lab (closing Sunday). Please reach out if you're interested in developing and applying methods to analyse microbial genomes and metagenomes! careers.petermac.org/job/MELBOURN...
🎉Dr. Lindsay Brubaker is tackling therapy resistance in #HGSC with cutting-edge research on antibody-drug conjugates (ADCs). Backed by a competitive DOD grant, her study explores epigenetic drivers to expand and improve treatment options. View Article bit.ly/4fxHr1E #OvarianCancer #CUAnschutz
📌
Single-cell analysis reveals the extent of genome doubling in ovarian cancer, its variability and its role in enabling tumours to evade the immune system
go.nature.com/4kJLAjZ
Today kicks off a major campaign by ANZGOG to highlight how common and impactful gynecological cancers are, even though each type individually is rare. #oncosky #cansky www.abc.net.au/news/2025-04...
🚨Scoop: Keynote speakers announced for the Australasian Genomic Technologies Association #AGTA25 Annual Conference #genomics #Sydney #Australia
We are recruiting a group leader in laboratory research at Peter Mac Cancer Centre in
Melbourne, Australia 🔬🦘💥
Work in a cutting edge research environment in a vibrant world city!
We value research excellence, creativity and diversity.
Join us!
careers.petermac.org/job/MELBOURN...
It was an honor to be awarded the Peter Mac Sambrook Prize in 2024 with Nikki Burdett for our work in Nature Genetics examining treatment resistance in ovarian cancer rdcu.be/d2kOC
